GPT Healthcare

138.61
+3.05
(2.25%)
ann
There are new updates from the company11 hours ago
Viewcross
right
Market Cap
1,137.36 Cr
EPS
5.22
PE Ratio
25.82
Dividend Yield
2.67 %
52 Week High
208.45
52 Week Low
126.10
PB Ratio
5.62
Debt to Equity
0.76
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,129.40
#1 1,09,792.59
102.90
5,584.10
18.77
#1 1,058
-17.46
59.65
6,492.05
93,345.72
71.54
#1 19,165.50
14.74
917
49.14
54.11
671.80
50,718.09
61.76
6,931.20
8.99
645
#1 89.49
62.72
1,673.40
34,197.74
42.51
5,093.40
10.96
790
2.66
65.20
1,213.85
32,602.48
64.67
2,759.20
#1 25.09
326
15.71
53.06
622.50
24,908.65
70.52
2,511.20
12.94
336
20.76
61.44
453.35
22,645.42
83.71
3,723.70
22.85
205
-69.22
62.46
1,378.50
13,998.90
56.82
1,334.00
10.76
218
10.06
59.81
5,180.00
11,456.25
#1 27.61
599.90
11.69
58
8.85
42.49
1,536.85
10,076.51
57.85
1,095.50
21.32
177
20.14
46.80
Growth Rate
Revenue Growth
37.57 %
Net Income Growth
97.63 %
Cash Flow Change
53.50 %
ROE
67.13 %
ROCE
54.46 %
EBITDA Margin (Avg.)
3.97 %

Yearly Financial Results

Annual Financials
2020
2021
2022
TTM
Revenue
216
249
342
0
Expenses
176
194
264
0
EBITDA
40
55
79
0
Operating Profit %
17 %
20 %
22 %
0 %
Depreciation
11
13
14
0
Interest
14
14
11
0
Profit Before Tax
15
29
54
0
Tax
4
8
12
0
Net Profit
11
21
42
0
EPS in ₹
4.11
7.92
5.22
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
Total Assets
309
317
323
Fixed Assets
226
220
220
Current Assets
63
86
86
Capital Work in Progress
2
0
1
Investments
1
1
10
Other Assets
80
97
92
Total Liabilities
309
317
323
Current Liabilities
65
60
69
Non Current Liabilities
117
123
97
Total Equity
127
134
158
Reserve & Surplus
69
76
78
Share Capital
18
18
80

Cash Flow

Cash Flow
2020
2021
2022
Net Cash Flow
-1
4
4
Investing Activities
-54
-17
-5
Operating Activities
42
43
66
Financing Activities
12
-22
-57

Share Holding

% Holding
Oct 2021
Oct 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
99.97 %
67.34 %
65.57 %
65.57 %
65.57 %
65.57 %
65.57 %
FIIs
0.00 %
0.00 %
0.00 %
6.68 %
5.38 %
4.70 %
4.72 %
DIIs
0.00 %
0.00 %
10.07 %
12.81 %
13.08 %
11.99 %
11.30 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
17.14 %
12.16 %
13.61 %
15.07 %
15.33 %
Others
0.03 %
32.66 %
7.22 %
2.78 %
2.35 %
2.66 %
3.08 %
No of Share Holders
9
9
9
76,664
71,293
74,737
70,147

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5 3.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.84 2.53 0.00

Corporate Action

Announcements

Closure of Trading Window11 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Integrated Filing (Financial)Feb 11, 2025
Results-Financial Results For The 3Rd Quarter Ended December 31 2024.Feb 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated February 11 2025.Feb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone) Along With Limited Review Report Of The Statutory Auditor Thereon Of The Company For The 3Rd QuarterJan 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 03, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsDec 05, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 15, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2024
Corporate Action-Board approves DividendNov 14, 2024
Results-Financial Results For 2Nd Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Q2FY25 ResultsNov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2024
Board Meeting Intimation for Considering Inter Alia And Approving The Unaudited Financial Results (Standalone) Of The Company For The 2Nd Quarter And Half Year Ended On September 30, 2024 And To Declare Interim Dividend For The Financial Year 2024-25.Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Closure of Trading WindowSep 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 14, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 13, 2024
Submission Of Un-Audited Financial Results For The Quarter Ended June 30, 2024Aug 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 13, 2024Aug 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2024
Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results Along With Report Of The Statutory Auditors Thereon Of The Company For The 1St Quarter Ended June 30, 2024.Aug 07, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportJul 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 25, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 15, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2024
Reg. 34 (1) Annual Report.Jul 01, 2024
Shareholders Meeting-35Th AGM On Thursday, July 25, 2024Jul 01, 2024
Closure of Trading WindowJun 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 25, 2024
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (As Amended).Jun 25, 2024

Technical Indicators

RSI(14)
Neutral
45.00
ATR(14)
Volatile
6.72
STOCH(9,6)
Neutral
52.05
STOCH RSI(14)
Neutral
51.41
MACD(12,26)
Bullish
1.31
ADX(14)
Strong Trend
29.87
UO(9)
Bearish
39.31
ROC(12)
Downtrend And Accelerating
-0.28
WillR(14)
Neutral
-63.07